Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heyltex
Katy, Texas, USAheyltex.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Heyltex is a specialty pharmaceutical company based in Katy, Texas, serving as the exclusive U.S. subsidiary of the German firm Heyl Chemisch-pharmazeutische Fabrik. The company focuses on the distribution and marketing of critical antidotes and decorporation agents used in toxicology and emergency preparedness. Its flagship product, Radiogardase (Prussian blue), is FDA-approved for treating patients with known or suspected internal contamination with radioactive cesium or non-radioactive thallium. Heyltex plays a vital role in public health by providing essential medical countermeasures for radiological emergencies and heavy metal poisoning.
- Therapeutic areas
- Rare Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
U.S. Department of Health and Human ServicesCenters for Disease Control and PreventionStrategic National Stockpile
Beyond the preview
Go deeper on Heyltex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heyltex.